Subscribe
handshake-1
miodrag ignjatovic / iStockphoto.com
18 September 2018Americas

Allergan to acquire medical aesthetics company for $195m

Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Allergan to buy Australian tissue repair company for $95m
12 February 2018   Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million.
Americas
Allergan completes $2.9bn acquisition of LifeCell
6 February 2017   Allergan has completed its acquisition of LifeCell, a Canada-based regenerative medicine company, for $2.9 billion.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Asia-Pacific
Allergan to buy Australian tissue repair company for $95m
12 February 2018   Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million.
Americas
Allergan completes $2.9bn acquisition of LifeCell
6 February 2017   Allergan has completed its acquisition of LifeCell, a Canada-based regenerative medicine company, for $2.9 billion.

More on this story

Asia-Pacific
Allergan to buy Australian tissue repair company for $95m
12 February 2018   Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million.
Americas
Allergan completes $2.9bn acquisition of LifeCell
6 February 2017   Allergan has completed its acquisition of LifeCell, a Canada-based regenerative medicine company, for $2.9 billion.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool